指南与共识神经头颈CTMR

ACR适宜性标准®:神经内分泌影像学

ACR Appropriateness Criteria® Neuroendocrine Imaging.
指南 / 共识 · J Am Coll Radiol · 2019-01-01

该指南针对疑似垂体功能亢进或减退的神经内分泌功能障碍,指出高分辨率MRI是评估蝶鞍及鞍旁区域的最佳一线检查,CT可补充骨质信息并在特定情况下可作一线检查但细节和病变特征不如MRI;指南由多学科专家组基于文献和RAND/UCLA适宜性方法及GRADE分级制定。

要点

  • 高分辨率MRI是评估蝶鞍和鞍旁区域的最佳一线检查。
  • CT可提供骨质解剖的补充信息,在特定情况下可作一线检查,但细节和病变特征不如MRI。
  • 蝶鞍和鞍旁区域病变包括垂体微腺瘤、大腺瘤及鞍上池 extrinsic 肿块,出血并发症可致激素功能障碍。

核心结论

  • 高分辨率MRI是评估蝶鞍及鞍旁区域的最佳一线检查。
  • CT可提供骨质解剖的补充信息,在特定情况下可作一线检查,但细节和病变特征不如MRI。

研究设计与样本

  • 美国放射学会(ACR)适宜性标准,由多学科专家小组每年审查,基于同行评议期刊文献的广泛分析及RAND/UCLA适宜性方法和GRADE分级制定。
  • 证据不足或模棱两可时,专家意见可补充现有证据以推荐影像或治疗。

关键影像表现/征象

  • 神经内分泌功能障碍的病因病变包括垂体原发肿块如垂体微腺瘤和大腺瘤,以及通常位于鞍上池的 extrinsic 肿块。
  • 与激素功能障碍相关的临床综合征可由激素分泌过多引起,或由肿块对下丘脑-垂体轴元件的占位效应抑制分泌所致。
  • 在 underlying 肿块背景下可见出血等并发症,并可导致激素功能障碍。

临床应用与阅片要点

  • 评估疑似垂体功能亢进或减退时,首选高分辨率MRI检查蝶鞍和鞍旁区域。
  • CT可补充骨质解剖信息,在特定情况下可作一线检查,但病变细节和特征不如MRI。

局限性

  • 证据不足或模棱两可时,专家意见可补充现有证据以推荐影像或治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Neuroendocrine dysfunction includes suspected hyper- and hypofunction of the pituitary gland. Causative lesions may include primary masses of the pituitary such as pituitary microadenomas and macroadenomas, as well as extrinsic masses, typically centered in the suprasellar cistern. Clinical syndromes related to hormonal dysfunction can be caused by excessive hormonal secretion or by inhibited secretion due to mass effect upon elements of the hypothalamic-pituitary axis. Additionally, complications such as hemorrhage may be seen in the setting of an underlying mass and can result in hormonal dysfunction. MRI with high-resolution protocols is the best first-line test to evaluate the sella turcica and parasellar region. CT provides complementary information regarding bony anatomy, and may be appropriate as a first-line test in certain instances, but it provides less detail and lesion characterization when compared to MRI. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Burns J, Policeni B, Bykowski J, et al. ACR Appropriateness Criteria® Neuroendocrine Imaging. J Am Coll Radiol. 2019. PMID: 31054742. doi:10.1016/j.jacr.2019.02.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。